TAG Treatment Action Group Inc
TAG Treatment Action Group Inc
Want to make a donation using Daffy?
Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.
Do you work for TAG Treatment Action Group Inc? Learn more here.
About this organization
Mission
Treatment Action Group (TAG) is an independent, activist, and community-based research and policy think tank committed to racial, gender, and LGBTQ+ equity; social justice; and liberation, fighting to end HIV, tuberculosis (TB), and hepatitis C virus (HCV). TAG catalyzes open collective action by affected communities, scientists, and policymakers to ensure that all people living with or impacted by HIV, TB, or HCV — especially communities of color and other marginalized communities experiencing inequities — receive life-saving prevention, diagnosis, treatment, care, and information. We are science-based activists working to expand and accelerate vital research. TAG catalyzes open collective action by all affected communities, scientists, and policy makers to end AIDS, TB and HCV.
About
See the schedule of HIV program in 2017. According to the December 2018 UNAIDS report, approximately 36.9 million people were living with HIV, 1.8 million became newly infected, and approximately one million people worldwide died of HIV disease. Despite the existence of effective prevention and treatment interventions, they are not reaching many who need them. This immense public health failure is due to a dense web of medical, political, and economic problems. Most of the world's people living with HIV reside in developing countries where many obstacles prevent the widespread distribution of HIV drugs. But even the most effective existing drugs have shortcomings, and people living with HIV everywhere need better treatment strategies and, ultimately, a cure that can be used worldwide to end the epidemic along with a safe and effective HIV vaccine. TAG's HIV program reviews the state of research on antiretroviral drug discovery, development, dissemination, and post-marketing surveillance. The HIV program advocates for accelerated access to treatments; innovation in the development of treatments that are active against drug-resistant HIV; and development of HIV treatments that are easier to take, associated with fewer side effects, and affordable to health care systems and people living with HIV. TAG's HIV program works with community members, scientists, and policy makers to enhance public understanding of the science of HIV infection, address gaps in HIV research, critique research efforts, and foster cross-disciplinary collaborations with the aim of accelerating research on HIV pathogenesis and the development of effective immune-based therapies and preventive technologies, with a particular focus on research advocacy around a cure for HIV. Program staff also works on domestic and international treatment guidelines to ensure that formulary determinations and prescribing practices are driven by sound scientific data. The HIV program tracks and analyzes resources devoted to HIV prevention and combined prevention technologies. The program advocates for local, state, and national agencies and AIDS service organizations to have increased awareness of current prevention tools, along with myriad structural barriers slowing their uptake, in order to stop transmission of HIV and thus end the epidemic. Program members work on New York State Governor Andrew M. Cuomo's ending the epidemic strategy and serve on its ending the epidemic subcommittee of the AIDS advisory council. This effort is part of a broader program by community activists, policy makers, advocates, and researchers to end the epidemic by stemming new infections and ensuring that HIV-positive people receive care, are retained in active care, and remain virally suppressed. In 2018, TAG worked with the Act Now End AIDS (ANEA) coalition to publish a road-map for a U.S. ending the HIV epidemic program, including proposals to end the related epidemics of hepatitis C virus (HCV), sexually transmitted infections [STIs], and tuberculosis (TB). In 2018, TAG worked with partners in Alabama, Louisiana, North Carolina, Texas, and in Jackson, MI, and Memphis, TN, to establish partnerships in those jurisdictions to create locally-led and governed ending-the-HIV-epidemic initiatives. As part of the HIV program, TAG's Basic Science, Vaccines, and Cure Project (BSVC) works with HIV community members, scientists, and policy makers to enhance public understanding of the science of HIV infection, address gaps in HIV research, critique the research effort, and foster cross-disciplinary collaborations to accelerate research into understanding how HIV causes disease (HIV pathogenesis) and speed the development of effective immune-based therapies, vaccines, and a cure. TAG's BSVC works to support and accelerate research into curing HIV infection; promote the rigorous evaluation of new immune-based therapeutic approaches, including therapies to reduce immune activation and improve immune reconstitution; accelerate the development of effective biomedical technologies to prevent HIV infections, including vaccines, microbicides, and preexposure prophylaxis; communicate and explain new findings in the basic science of HIV to HIV community members and policy makers; and ensure that community priorities help shape research into pathogenesis, immunology, immune-based therapies, and preventive technologies. The HIV program works with global and domestic partners for universal access to high-quality HIV prevention, treatment, and care programs.
Interesting data from their 2020 990 filing
The purpose of the non-profit is outlined in the filing as “Tag works to ensure that all people with hiv, tb, or hcv receive lifesaving treatment, care, and information. tag is science-based treatment activists working to expand and accelerate vital research and effective community engagement with research and policy institutions. tag catalyzes open collective action by all affected communities, scientists, and policy makers to end hiv, tb, and hcv.”.
When discussing its operations, they were defined as: “T.a.g. treatment action group, inc. ("tag") is a not-for-profit organization incorporated under the laws of the state of new york. founded in january 1992, tag is an independent, activist, and community-based research and policy think tank fighting for better treatment, prevention, a vaccine, and a cure for hiv, tuberculosis (tb), and hepatitis c virus (hcv). tag works to ensure that all people with hiv, tb, or hcv receive lifesaving treatment, care, and information. tag is science-based treatment activists working to expand and accelerate vital research and effective community engagement with research and policy institutions. tag catalyzes open collective action by all affected communities, scientists, and policy makers to end hiv, tb, and hcv.the primary sources of revenue to tag are contributions and grants.”.
- The state where the non-profit operates has been legally reported as NY.
- The filing indicates that the non-profit's address in 2020 is located at 90 BROAD STREET NO 2503, NEW YORK, NY, 10004.
- The non-profit has reported 17 employees on their form as of 2020.
- Is not a private foundation.
- Expenses are greater than $1,000,000.
- Revenue is greater than $1,000,000.
- Revenue less expenses is -$701,749.
- The organization has 18 independent voting members.
- The organization was formed in 1992.
- The organization pays $1,520,496 in salary, compensation, and benefits to its employees.
- The organization pays $163,942 in fundraising expenses.
Additional Non-Profits in the area
By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.